Company Filing History:
4 out of 2,103 
1 out of 3,923 
1 out of 1,271 
Years Active: 2016-2023
Title: The Innovative Journey of Frederick Simmons Buckner
Introduction
Frederick Simmons Buckner is an accomplished inventor based in Seattle, Washington, known for his significant contributions to the field of biochemistry. With a total of four patents to his name, he has made strides in understanding and manipulating the mechanisms of methionyl-tRNA synthetase, an essential enzyme in protein synthesis. His innovative work has broad implications for the treatment of various diseases.
Latest Patents
Among Buckner's noteworthy patents are two focused on inhibitors of type 1 methionyl-tRNA synthetase. The first patent, titled "Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them," describes compositions that are instrumental in inhibiting MetRS and provides methods for treating diseases that benefit from this inhibition. The second patent, "Specific inhibitors of methionyl-tRNA synthetase," elaborates on similar compositions valuable for therapeutic purposes, emphasizing their potential in disease treatment.
Career Highlights
Frederick Buckner has had a distinguished career, collaborating with leading educational institutions such as the University of Washington and the University of North Carolina at Chapel Hill. His research and inventions have not only advanced scientific knowledge but have also paved the way for future innovations in the realm of enzymatic function and disease treatment.
Collaborations
During his time in various research capacities, Buckner has had the opportunity to work alongside esteemed colleagues, including John Robert Gillespie and Erkang Fan. These collaborations have fostered an environment of shared knowledge and innovation, further amplifying the impact of Buckner's inventions in the scientific community.
Conclusion
Frederick Simmons Buckner stands as a prominent figure in the landscape of modern biochemistry and patenting. His inventive work on methionyl-tRNA synthetase inhibitors showcases his dedication to advancing medical science and addressing complex health challenges. As research continues to evolve, Buckner's contributions will likely inspire future innovations and collaborations in the field.